U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Thyroid cancer a risk after childhood cancer

Printer-friendly version E-mail this page to a friend

Reuters Health

Tuesday, October 27, 2009

NEW YORK (Reuters Health) - Childhood cancer survivors are 18 times more likely to develop thyroid cancer than the general population, UK researchers report.

"Survival after childhood cancer has greatly improved over the last three decades with 5-year survival 75 percent during the 1990s compared to 25 percent during the 1960s in the United Kingdom," Dr. Aliki J. Taylor, of the University of Birmingham, and colleagues note in the latest issue of the International Journal of Cancer.

Childhood cancer survivors are at an increased risk of "late effects" of treatment, including the development of second cancers.

To assess the risk of developing thyroid cancer, the researchers analyzed data from 17,980 patients who were enrolled in The British Childhood Cancer Survivor Study and had survived at least 5 years after diagnosis with a childhood cancer from 1940 to 1991.

During a median follow-up of 17.4 years per survivor, 50 cases of thyroid cancer were identified, compared to 2.8 expected in the general population.

Forty-four patients (88 percent) who developed thyroid cancer had received radiation therapy in or around the thyroid gland.

Patients treated radiation therapy for childhood cancer had a greater than fourfold increased risk of developing thyroid cancer, the researchers found.

"These results will be of use in counseling survivors of childhood cancer exposed to radiation in or around the thyroid area," Taylor and colleagues conclude.

SOURCE: International Journal of Cancer, November 15, 2009.


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: